Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Chemical Engineers are Beginning to Play a Leading Role in the Treatment of Cancers

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
Engineers are helping to combat drug resistance and finding better ways of delivering treatments directly at tumours.

Cancer treatments often include a mix of therapies including chemotherapy, growth inhibitors and radiation therapy.

Success is dependent on many factors, but multi-drug resistance by the cancerous cells and the inability to deliver chemotherapy treatments directly to tumours in high enough concentrations are just some of the obstacles to a successful outcome.

It’s a problem which is attracting the attention of chemical engineers who are looking at new ways to treat cancer. One example is using ‘nanomaterials’ to carry drugs into affected areas in combination with experimental photothermal therapies.

Nanomaterials, such as Nanographene oxide (NGO), are able to penetrate the relatively large gaps (100-600nm) found in tumours to target cancerous cells more effectively.  By changing the size and surface properties of the nanomaterials, chemical engineers are also able to control how the drugs are distributed around the body to help avoid damaging non-cancerous cells.

Drugs carried by nanomaterials have other distinct advantages over ‘small molecule drugs’, which are quickly metabolised and removed from the human body by the kidneys. Standard drugs also have greater side effects caused by the high dosages needed to treat the cancers.

A recent study1 by chemical engineers in Taiwan, using nanomaterials technology combined with other cancer treatments, were able to increase the local drug concentration six fold and suppress tumour development more efficiently. Their results also suggested treatment was less toxic, with reduced side effects, and no multi-drug resistance.

David Brown, chief executive of the Institution of Chemical Engineers (IChemE), said: “Recent analysis by the charity Macmillan Cancer Support projects that in 2020 nearly one in two people (47%) in the UK will get cancer in his or her lifetime.

“These are dramatic statistics and put increasing pressure on the health sector and professionals like chemical engineers to find better treatments and cures for cancer.

“It’s great to see chemical engineers making their own significant contribution in this field in this latest piece of research from Taiwan and other projects we know are underway in many other countries around the world.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Artificial Nose Matches Human Sense of Smell
Chemical engineers in South Korea have successfully created nanobioelectronic nose.
Monday, June 24, 2013
Scientific News
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Cancer Cells Coordinate to Form Roving Clusters
Rice University scientists identify ‘smoking gun’ in metastasis of hybrid cells.
Genes For Nose Shape Found
Genes that drive the shape of human noses have been identified by a UCL-led study.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!